Marina Cavazzana-Calvo is the Head of the Department of Biotherapy at Necker Children’s Hospital (Paris). In 2001, she qualified in transfusion technologies at the Franche-Comté University. She is also since 2000 a University professor and hospital practitioner (Paris V University). She obtained her Ph.D in blood cell biology in 1993 at Paris VII University in the laboratory of Prof. Alain Fischer. She is member of the American Society of Gene Therapy Hematopoietic Committee since 2005, member of AFM (French Muscular Dystrophy Association) Commission for clinical trials (2002), chairwoman of the group “Hereditary diseases for the European Group for Blood and Marrow Transplantation” (2002), member of the Scientific Committee of the French Medicines Agency and the Clinical Trials Commission also since 2002, member of the Biotherapy consortium of researchers at INSERM since 2000, chairwoman of the sub-committee “Thematics of Research: Therapeutic Innovation” of the Lyon Public Hospitals since 2000 and member of the consortium of researchers “Constituted lymphocyte hemostasis” for the National Agency of AIDS Research (1999).

Since 1997, she is an expert within the French Agency for The Safety of Health Products. She obtained the following scientific awards: Prix Jean-Pierre Lecocq, French Academy of Sciences (2004), Knight of the National order of the Legion d’Honneur in 2001, Special Medical Award from the Academy of Sciences and Prestigious Award from Toulouse for work on gene and cell therapy in 2000, American Society of Hematology Award for clinical research in Gene Therapy (1999), Philip Morris Scientific Award on Gene Therapy (1999) and the Medical Research Foundation Award on Clinical Research (1997).